These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Controlled clinical study of an association of cresotamide and d-propoxyphene phenylbutazonate in (Midalgyl) in urology]. Borghi M; Cicchetti F Minerva Urol; 1972; 24(4):145-56. PubMed ID: 4614054 [No Abstract] [Full Text] [Related]
5. [Use of a new antalgic anti-inflammatory agent in otorhinolaryngology]. Portmann M; Pardes P Rev Laryngol Otol Rhinol (Bord); 1971; 92(3):235-8. PubMed ID: 5565287 [No Abstract] [Full Text] [Related]
6. [On the treatment of rheumatic diseases with Delta-Tomanol]. Wille T Ther Ggw; 1968 Nov; 107(11):1512-4 passim. PubMed ID: 5306056 [No Abstract] [Full Text] [Related]
8. [Use of a new antirheumatic drug: midalgyl]. Vignon G; Laurent J; Kopp N Presse Med (1893); 1970 Nov; 78(48):2145-6. PubMed ID: 5312370 [No Abstract] [Full Text] [Related]
9. [On the use in anti-rheumatic therapy of a new non-steroid anti-inflammatory agent: glucosamide of monohydrated (N-p-chloro-benzoyl-2-methyl-5-methoxy)-indol-3-acetic acid]. De Arcangelis A Clin Ter; 1971 Nov; 59(3):229-39. PubMed ID: 5316735 [No Abstract] [Full Text] [Related]
10. [Which anti-inflammatory agents should be used in rheumatology?]. Gerster JC Schweiz Med Wochenschr; 1981 Feb; 111(8):266-71. PubMed ID: 7015496 [TBL] [Abstract][Full Text] [Related]
11. Selection of analgesics in the treatment of the rheumatic disorders. Hart FD Proc R Soc Med; 1969 Jun; 62(6):539-40. PubMed ID: 5306583 [No Abstract] [Full Text] [Related]
12. [Preliminary observations on the clinical use of the glucosamide of N-p-chlorobenzoyl-2-methyl-5-methoxy-indol-3-acetic acid monohydrate]. Montini M; Ongaro A; Pagani G Reumatismo; 1972; 24(1):57-68. PubMed ID: 4546498 [No Abstract] [Full Text] [Related]
13. [Considerations on the use of aminophenazone and aminopropylon in equimolecular association in rheumatology]. Colamussi V; Bazzanini G Minerva Med; 1968 Jan; 59(3):71-8. PubMed ID: 5300479 [No Abstract] [Full Text] [Related]
14. [Clinical trial of a new anti-inflammatory agent in rheumatoid arthritis]. Soldati R; Sorbilli G; Di Benedetto P Clin Ter; 1978 Feb; 84(4):387-424. PubMed ID: 648098 [No Abstract] [Full Text] [Related]
15. [Controlled clinical research on the use of ibuprofen in rheumatoid arthritis and other rheumatic diseases]. Giordano M; Tirri G; Capelli L; Gallo M; Scott GG Minerva Med; 1973 Jun; 64(47):2483-90. PubMed ID: 4579840 [No Abstract] [Full Text] [Related]
16. [Effect of perclusone in rheumatic diseases]. Amatuni H Reumatologia; 1973 Jan; 11(1):37-42. PubMed ID: 4540529 [No Abstract] [Full Text] [Related]
17. [Value in rheumatology of a combination of a muscle relaxant, an analgesic and a corticoid]. Doury P Maroc Med; 1969 May; 49(524):296-9. PubMed ID: 5313398 [No Abstract] [Full Text] [Related]
18. [Clofezone, a new potent antirheumatic drug]. Kaiser H Munch Med Wochenschr; 1973 Dec; 115(49):2247-8. PubMed ID: 4205416 [No Abstract] [Full Text] [Related]
19. [Comparison of the effects of phenylbutazone and a combination preparation (Exrheudon) in rheumatic diseases]. Engel P MMW Munch Med Wochenschr; 1977 Jan; 119(3):93-4. PubMed ID: 403430 [No Abstract] [Full Text] [Related]
20. Naproxen. Proceedings from an International Medical Symposium presented by Syntex Corporation 7-8 May 1973, Geneva, Switzerland. Scand J Rheumatol Suppl; 1973; 2():1-181. PubMed ID: 4544036 [No Abstract] [Full Text] [Related] [Next] [New Search]